High-dose pralidoxime for organophosphorus poisoning

Lancet. 2007 Apr 28;369(9571):1426. doi: 10.1016/S0140-6736(07)60659-X.

Authors

Rajnish Joshi¹, S P Kalantri²

Affiliations

¹ Department of Medicine, Mahatma Gandhi Institute of Medical Sciences Sevagram, Maharashtra 442102, India; Division of Epidemiology, School of Public Health, University of California, Berkeley, CA, USA.
² Department of Medicine, Mahatma Gandhi Institute of Medical Sciences Sevagram, Maharashtra 442102, India. Electronic address: sp.kalantri@gmail.com.

PMID: 17467504
DOI: 10.1016/S0140-6736(07)60659-X

No abstract available

Publication types

Comment
Letter

MeSH terms

Atropine / therapeutic use*
Cholinesterase Reactivators / economics
Cholinesterase Reactivators / therapeutic use*
Clinical Trials as Topic
Ethics, Research*
Humans
Mortality*
Muscarinic Antagonists / therapeutic use*
Organophosphate Poisoning*
Pralidoxime Compounds / economics
Pralidoxime Compounds / therapeutic use*

Substances

Cholinesterase Reactivators
Muscarinic Antagonists
Pralidoxime Compounds
Atropine
pralidoxime